Download PDFOpen PDF in browserTargeting Mycobacterial Cell Wall Integrity: Exploring the Synergistic Potential of Q203 and PBTZ169EasyChair Preprint 118787 pages•Date: January 29, 2024AbstractThis research delves into a groundbreaking exploration of synergistic interactions between two promising anti-tubercular agents, Q203 and PBTZ169, with a focus on targeting mycobacterial cell wall integrity. Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), poses a significant global health threat, demanding innovative therapeutic strategies. Q203, a potent respiratory inhibitor, and PBTZ169, known for its impact on cell wall synthesis, exhibit individual efficacies against TB. The study aims to unravel the synergistic potential of their combination, seeking enhanced efficacy and improved treatment outcomes. Keyphrases: Cell, Mycobacterial, wall
|